borderline significantp = 0.039
Further, at 12 weeks, fasting insulin levels were 7.5 mU/L higher in the placebo group compared to the treatment group and this trend was borderline significant ( p = 0.039).
Further, at 12 weeks, fasting insulin levels were 7.5 mU/L higher in the placebo group compared to the treatment group and this trend was borderline significant ( p = 0.039).